228 related articles for article (PubMed ID: 32528464)
1. Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
Ottria A; Hoekstra AT; Zimmermann M; van der Kroef M; Vazirpanah N; Cossu M; Chouri E; Rossato M; Beretta L; Tieland RG; Wichers CGK; Stigter E; Gulersonmez C; Bonte-Mineur F; Berkers CR; Radstake TRDJ; Marut W
Front Immunol; 2020; 11():822. PubMed ID: 32528464
[TBL] [Abstract][Full Text] [Related]
2. Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients.
Fernández-Ochoa Á; Quirantes-Piné R; Borrás-Linares I; Gemperline D; ; Alarcón Riquelme ME; Beretta L; Segura-Carretero A
J Pharm Biomed Anal; 2019 Jan; 162():82-90. PubMed ID: 30227356
[TBL] [Abstract][Full Text] [Related]
3. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into dendritic cells in the pathogenesis of systemic sclerosis.
Carvalheiro T; Zimmermann M; Radstake TRDJ; Marut W
Clin Exp Immunol; 2020 Jul; 201(1):25-33. PubMed ID: 31970748
[TBL] [Abstract][Full Text] [Related]
5. Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis.
Rossato M; Affandi AJ; Thordardottir S; Wichers CGK; Cossu M; Broen JCA; Moret FM; Bossini-Castillo L; Chouri E; van Bon L; Wolters F; Marut W; van der Kroef M; Silva-Cardoso S; Bekker CPJ; Dolstra H; van Laar JM; Martin J; van Roon JAG; Reedquist KA; Beretta L; Radstake TRDJ
Arthritis Rheumatol; 2017 Sep; 69(9):1891-1902. PubMed ID: 28556560
[TBL] [Abstract][Full Text] [Related]
6. Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis.
Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
Cells; 2021 Dec; 10(12):. PubMed ID: 34943909
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in systemic sclerosis: Advances from human and mice studies.
Affandi AJ; Carvalheiro T; Radstake TRDJ; Marut W
Immunol Lett; 2018 Mar; 195():18-29. PubMed ID: 29126878
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic profile of systemic sclerosis patients.
Murgia F; Svegliati S; Poddighe S; Lussu M; Manzin A; Spadoni T; Fischetti C; Gabrielli A; Atzori L
Sci Rep; 2018 May; 8(1):7626. PubMed ID: 29769578
[TBL] [Abstract][Full Text] [Related]
10. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
11. Early inflammatory players in cutanous fibrosis.
Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
[TBL] [Abstract][Full Text] [Related]
13. Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.
Ruiz M; Labarthe F; Fortier A; Bouchard B; Thompson Legault J; Bolduc V; Rigal O; Chen J; Ducharme A; Crawford PA; Tardif JC; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H768-H781. PubMed ID: 28710072
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
[TBL] [Abstract][Full Text] [Related]
15. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
[TBL] [Abstract][Full Text] [Related]
16. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
[TBL] [Abstract][Full Text] [Related]
17. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
18. Novel insights on the role of the innate immune system in systemic sclerosis.
York MR
Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
[TBL] [Abstract][Full Text] [Related]
19. CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis.
Mokuda S; Miyazaki T; Ubara Y; Kanno M; Sugiyama E; Takasugi K; Masumoto J
Arthritis Res Ther; 2015 Sep; 17():275. PubMed ID: 26419626
[TBL] [Abstract][Full Text] [Related]
20. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
